Brinker Capital Investments’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.24M | Buy |
23,508
+303
| +1% | +$29.1K | 0.02% | 735 |
|
|
2026
Q1 | $2.4M | Sell |
23,205
-1,637
| -7% | -$186K | 0.02% | 672 |
|
|
2025
Q4 | $2.5M | Buy |
24,842
+16,038
| +182% | +$1.74M | 0.02% | 733 |
|
|
2025
Q3 | $1.09M | Sell |
8,804
-21,665
| -71% | -$2.69M | 0.01% | 1181 |
|
|
2025
Q2 | $3.66M | Buy |
30,469
+6,032
| +25% | +$805K | 0.03% | 504 |
|
|
2025
Q1 | $3.6M | Sell |
24,437
-5,839
| -19% | -$892K | 0.04% | 458 |
|
|
2024
Q4 | $4.92M | Sell |
30,276
-10,944
| -27% | -$1.79M | 0.05% | 336 |
|
|
2024
Q3 | $6.72M | Buy |
41,220
+1,469
| +4% | +$218K | 0.07% | 278 |
|
|
2024
Q2 | $5.42M | Buy |
39,751
+4,043
| +11% | +$561K | 0.06% | 294 |
|
|
2024
Q1 | $5.47M | Sell |
35,708
-1,255
| -3% | -$187K | 0.06% | 303 |
|
|
2023
Q4 | $5.26M | Buy |
36,963
+10,704
| +41% | +$1.43M | 0.06% | 298 |
|
|
2023
Q3 | $3.44M | Buy |
26,259
+1,418
| +6% | +$215K | 0.04% | 395 |
|
|
2023
Q2 | $3.95M | Buy |
24,841
+2,337
| +10% | +$377K | 0.04% | 385 |
|
|
2023
Q1 | $3.56M | Buy |
+22,504
| New | +$3.37M | 0.04% | 360 |
|
|
2021
Q1 | – | Sell |
-1,334
| Closed | -$269K | – | 1184 |
|
|
2020
Q4 | $269K | Buy |
+1,334
| New | +$276K | ﹤0.01% | 948 |
|
|
2020
Q1 | – | Sell |
-90
| Closed | -$14K | – | 378 |
|
|
2019
Q4 | $14K | Hold |
90
| – | – | ﹤0.01% | 538 |
|
|
2019
Q3 | $14K | Sell |
90
-583
| -87% | -$92.2K | ﹤0.01% | 543 |
|
|
2019
Q2 | $103K | Buy |
673
+551
| +452% | +$84.2K | ﹤0.01% | 474 |
|
|
2019
Q1 | $20K | Buy |
122
+32
| +36% | +$4.96K | ﹤0.01% | 551 |
|
|
2018
Q4 | $14K | Hold |
90
| – | – | ﹤0.01% | 470 |
|
|
2018
Q3 | $14K | Hold |
90
| – | – | ﹤0.01% | 455 |
|
|
2018
Q2 | $12K | Hold |
90
| – | – | ﹤0.01% | 475 |
|
|
2018
Q1 | $12K | Sell |
90
-2,737
| -97% | -$368K | ﹤0.01% | 447 |
|
|
2017
Q4 | $420K | Buy |
2,827
+326
| +13% | +$44.4K | 0.01% | 263 |
|
|
2017
Q3 | $330K | Buy |
2,501
+117
| +5% | +$15.7K | 0.01% | 258 |
|
|
2017
Q2 | $318K | Sell |
2,384
-284
| -11% | -$38.3K | 0.01% | 253 |
|
|
2017
Q1 | $360K | Buy |
2,668
+430
| +19% | +$55.7K | 0.01% | 238 |
|
|
2016
Q4 | $269K | Buy |
2,238
+253
| +13% | +$29.8K | 0.01% | 247 |
|
|
2016
Q3 | $248K | Buy |
1,985
+157
| +9% | +$20.6K | 0.01% | 244 |
|
|
2016
Q2 | $253K | Buy |
1,828
+33
| +2% | +$4.28K | 0.01% | 246 |
|
|
2016
Q1 | $226K | Sell |
1,795
-335
| -16% | -$42.6K | 0.01% | 258 |
|
|
2015
Q4 | $270K | Buy |
2,130
+233
| +12% | +$28.9K | 0.01% | 272 |
|
|
2015
Q3 | $219K | Buy |
1,897
+1,831
| +2,774% | +$206K | 0.01% | 271 |
|
|
2015
Q2 | $7K | Hold |
66
| – | – | ﹤0.01% | 375 |
|
|
2015
Q1 | $7K | Hold |
66
| – | – | ﹤0.01% | 384 |
|
|
2014
Q4 | $7K | Buy |
+66
| New | +$6.6K | ﹤0.01% | 375 |
|
|
2013
Q3 | – | Sell |
-2,046
| Closed | -$170K | – | 373 |
|
|
2013
Q2 | $170K | Buy |
+2,046
| New | +$176K | 0.01% | 265 |
|
Other funds holding CLX
Brinker Capital Investments's CLX Position: Q2 2026 in Review
Brinker Capital Investments increased its Clorox (CLX) stake by 1.3% in Q2 2026, buying an estimated $29.1K and bringing the position to 23,508 shares worth $2.24M. The position accounts for 0.02% of the portfolio, ranked #735.
Brinker Capital Investments first reported a position in CLX in Q2 2013 and has held it in 37 quarters since. The position peaked at $6.72M in Q3 2024. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- Brinker Capital Investments held 23,508 shares of Clorox worth $2.24M as of Q2 2026.
- Brinker Capital Investments bought 303 Clorox shares in Q2 2026, an estimated $29.1K.
- Clorox made up 0.02% of Brinker Capital Investments's portfolio in Q2 2026, its #735 holding.
- Brinker Capital Investments first reported a position in Clorox in Q2 2013 and has held it in 37 quarters since.
- Brinker Capital Investments's Clorox position peaked at $6.72M in Q3 2024.
- 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.